Document Detail


Crystalloid cardioplegia and hypothermia do not impair endothelium-dependent relaxation or damage vascular smooth muscle of epicardial coronary arteries.
MedLine Citation:
PMID:  1434718     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Canine hearts were arrested with crystalloid cardioplegic solution (45 minutes at 7 degrees C) to determine whether either cardioplegia or hypothermia impairs the production of endothelium-derived relaxing factor or damages the vascular smooth muscle of epicardial coronary arteries. In addition, isolated coronary artery segments were exposed to either cold (7 degrees C) or warm (37 degrees C) crystalloid cardioplegic solution and physiologic salt solution in vitro for 45 minutes. After cardiac arrest or incubation with the solutions, segments of epicardial coronary artery were prepared and studied in organ chambers. Cardioplegic arrest of the heart or exposure to cardioplegic solution in vitro (7 degrees or 37 degrees C) did not alter endothelium-dependent relaxation of epicardial coronary artery segments in response to adenosine diphosphate or acetylcholine (10(-9) to 10(-4) mol/L). Cardioplegic arrest did not alter G protein-mediated, endothelium-dependent relaxation in response to sodium fluoride. In addition, smooth muscle contraction in response to potassium ions (voltage-dependent) or prostaglandin F2 alpha (receptor-dependent) and relaxation in response to isoproterenol (cyclic adenosine monophosphate-mediated) or sodium nitroprusside (cyclic guanosine monophosphate-mediated) was unaltered after exposure to cardioplegic solution or hypothermia. These experiments demonstrate that hyperkalemic crystalloid cardioplegia does not irreversibly alter function of epicardial coronary arteries. We hypothesize that coronary artery endothelial cell dysfunction identified in previous studies of cardioplegia may have been due to the effects of barotrauma or shear stress on the vasculature and not the effect of cardioplegia per se.
Authors:
P R Evora; P J Pearson; H V Schaff
Related Documents :
3361928 - Enhancement of crystalloid cardioplegic protection against global normothermic ischemia...
3517508 - Nifedipine as an adjunct to st. thomas' hospital cardioplegia. a double-blind, placebo-...
2944358 - Myocardial protection of hypertrophied hearts by administration of cardioplegia accordi...
20605028 - Early reperfusion with warm, polarizing adenosine-lidocaine cardioplegia improves funct...
17996568 - F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of pat...
1597078 - Hemodynamic assessment of intravenous isosorbidi dinitras in coronary heart disease.
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  104     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  1992 Nov 
Date Detail:
Created Date:  1992-12-11     Completed Date:  1992-12-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1365-74     Citation Subset:  AIM; IM    
Affiliation:
Section of Cardiovascular Surgery, Mayo Clinic, Rochester, MN 55905.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcholine / pharmacology
Adenosine Diphosphate / pharmacology
Animals
Cardioplegic Solutions / pharmacology*
Coronary Vessels / drug effects*
Dogs
Dose-Response Relationship, Drug
Endothelium, Vascular / drug effects*
Female
Hypothermia, Induced / adverse effects*
Isoproterenol / pharmacology
Male
Muscle Contraction / drug effects
Muscle Relaxation / drug effects*
Muscle, Smooth, Vascular / drug effects*,  injuries
Potassium / pharmacology
Potassium Compounds*
Sodium Fluoride / pharmacology
Vasodilation / drug effects
Chemical
Reg. No./Substance:
0/Cardioplegic Solutions; 0/Potassium Compounds; 0/potassium cardioplegic solution; 51-84-3/Acetylcholine; 58-64-0/Adenosine Diphosphate; 7440-09-7/Potassium; 7681-49-4/Sodium Fluoride; 7683-59-2/Isoproterenol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed...
Next Document:  Enhancement of low coronary reflow improves postischemic myocardial function.